Physician

Dana F Graichen, M.D.

According to 2025 Medicare claims, Dana Graichen, M.D. (NPI: 1831176312) practices ophthalmology in the Portland-South Portland, ME market, with the plurality of this provider's patient population coming from York, ME. This provider's primary affiliated billing organization is EYESIGHT OPHTHALMIC SERVICES PLLC (NPI: 1073736310; TIN: 020395562) and primary practice location at 04073-1815. Graichen is affiliated with the MaineHealth Accountable Care Organization (ACO ID: A1290), participating under the MSSP model.

Graichen's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 526 traditional Medicare patients, billed 8,323 HCPCS/CPT codes, and received $824,594 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 77 prescription claims across 37 beneficiaries totaling $2,780 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 6 records totaling $140. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $44,392 to $2,780. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$506K$1.0M2015 Medicare payment: $922,801 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $935,975 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $910,235 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,012,285 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $876,970 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $754,146 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $678,114 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $649,892 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $665,931 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $824,594 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20159286,030$922,801
20169746,054$935,975
20179265,809$910,235
20189165,906$1,012,285
20198595,355$876,970
20207074,106$754,146
20216293,950$678,114
20225853,690$649,892
20235705,155$665,931
20245268,323$824,594

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$22K$44K2015 Drug cost: $44,392 (USD; Tot_Drug_Cst)2016 Drug cost: $40,682 (USD; Tot_Drug_Cst)2017 Drug cost: $34,975 (USD; Tot_Drug_Cst)2018 Drug cost: $31,637 (USD; Tot_Drug_Cst)2019 Drug cost: $33,066 (USD; Tot_Drug_Cst)2020 Drug cost: $15,588 (USD; Tot_Drug_Cst)2021 Drug cost: $7,253 (USD; Tot_Drug_Cst)2022 Drug cost: $6,651 (USD; Tot_Drug_Cst)2023 Drug cost: $5,221 (USD; Tot_Drug_Cst)2024 Drug cost: $2,780 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015187655$44,392
2016233713$40,682
2017239676$34,975
2018221524$31,637
2019237449$33,066
202074187$15,588
20213693$7,253
20224288$6,651
20232877$5,221
20243777$2,780

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg91505$654
92014Established patient complete exam of visual system318430$89
67028Injection of drug into eye117429$85
92012Established patient problem focused exam of visual system186431$65
92134Imaging of retina4571,215$30

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate18788$532
Ketorolac TromethamineKetorolac Tromethamine11460$154

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.6$140Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Dana F. Graichen, M.D.?

Tedicare shows public-source Medicare data for Dana F. Graichen, M.D. (NPI 1831176312), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Dana F. Graichen, M.D. have ACO affiliation data?

Dana F. Graichen, M.D. is shown with ACO affiliation data for MaineHealth Accountable Care Organization (MSSP, ACO ID A1290).

What billing organization is linked to Dana F. Graichen, M.D.?

Dana F. Graichen, M.D. is linked to EYESIGHT OPHTHALMIC SERVICES PLLC (billing NPI 1073736310) in the available physician profile data.

Does Dana F. Graichen, M.D. have Open Payments data?

Dana F. Graichen, M.D. has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.